HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wanggang Zhang Selected Research

Acute Monocytic Leukemia (Acute Monoblastic Leukemia)

1/2021Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia.
6/2017Prokaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technology.
2/2017Bioinformatic prediction and functional characterization of human KIAA0100 gene.
5/2005Serological identification of immunogenic antigens in acute monocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wanggang Zhang Research Topics

Disease

23Leukemia
01/2021 - 01/2004
14Neoplasms (Cancer)
01/2021 - 03/2010
14Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2020 - 05/2005
9Multiple Myeloma
12/2019 - 06/2012
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 02/2011
4Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
01/2021 - 05/2005
4Residual Neoplasm
01/2020 - 02/2011
3Carcinogenesis
01/2020 - 02/2017
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2020 - 09/2018
2Aplastic Anemia (Anemia, Hypoplastic)
12/2017 - 03/2016
1Airway Remodeling
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Anemia
01/2021
1Diarrhea
01/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021
1Edema (Dropsy)
01/2021
1Exanthema (Rash)
01/2021
1Hypophosphatemia
01/2021
1Blast Crisis (Blast Phase)
01/2021
1Pain (Aches)
01/2021
1Neutropenia
01/2021
1Philadelphia Chromosome
01/2021
1Iron Overload
02/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Immune System Diseases (Immune Disorders)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
10/2019
1Shock
10/2019
1Hyperthermia
10/2019
1Lymphoma (Lymphomas)
10/2019
1Respiratory Insufficiency (Respiratory Failure)
10/2019
1Disease Progression
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1Atherosclerosis
12/2018
1Cardiovascular Diseases (Cardiovascular Disease)
12/2018
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
02/2018
1Chromosome Aberrations (Chromosome Abnormalities)
07/2017
1Paralysis (Palsy)
01/2017
1IGA Glomerulonephritis (IGA Nephropathy)
01/2017
1T-Cell Lymphoma (Lymphoma, T Cell)
11/2016

Drug/Important Bio-Agent (IBA)

12AntigensIBA
01/2021 - 05/2005
7Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2008
5Pharmaceutical PreparationsIBA
06/2019 - 11/2010
4EpitopesIBA
01/2021 - 05/2005
4Peptides (Polypeptides)IBA
01/2021 - 01/2013
4Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2012
4MicroRNAs (MicroRNA)IBA
01/2020 - 11/2016
3HLA-A*02:01 antigenIBA
01/2021 - 12/2014
3Long Noncoding RNAIBA
06/2020 - 10/2017
3VaccinesIBA
01/2019 - 09/2012
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2018 - 04/2017
3Complementary DNA (cDNA)IBA
06/2017 - 01/2004
3Messenger RNA (mRNA)IBA
11/2016 - 05/2008
2CytokinesIBA
01/2021 - 11/2016
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2021 - 02/2011
2Therapeutic UsesIBA
01/2021 - 12/2010
2IronIBA
02/2020 - 05/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 05/2005
2thymoglobulinFDA Link
12/2017 - 03/2016
2CateninsIBA
01/2017 - 01/2015
2Cancer VaccinesIBA
09/2012 - 02/2011
1JNK Mitogen-Activated Protein KinasesIBA
01/2022
1CCCTC-Binding FactorIBA
01/2022
1pyrazolanthroneIBA
01/2022
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1Alanine Transaminase (SGPT)IBA
01/2021
1Protein Subunit VaccinesIBA
01/2021
1flumatinibIBA
01/2021
1Factor X (Stuart Factor)IBA
01/2020
1Caspase 3 (Caspase-3)IBA
01/2020
1Platelet Factor 4IBA
12/2019
1Thalidomide (Thalomid)FDA Link
12/2019
1Chimeric Antigen ReceptorsIBA
10/2019
1tocilizumab (atlizumab)FDA Link
10/2019
1Interleukin-17 (Interleukin 17)IBA
06/2019
1Nicotinamide PhosphoribosyltransferaseIBA
06/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Ribonuclease P (RNase P)IBA
01/2019
1Endothelins (Endothelin)IBA
12/2018
1oxidized low density lipoproteinIBA
12/2018
1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2018
1AclarubicinIBA
09/2018
1fluorine monoxideIBA
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
1Cell Surface ReceptorsIBA
01/2018
1Tumor Suppressor Protein p53IBA
01/2018
1Lanthanoid Series Elements (Lanthanides)IBA
01/2018
1fms-Like Tyrosine Kinase 3IBA
07/2017
1DNA Methyltransferase 3AIBA
07/2017
1Combined VaccinesIBA
04/2017
1Arsenic Trioxide (Trisenox)FDA Link
01/2017
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2017
1Interleukin-10 (Interleukin 10)IBA
01/2017

Therapy/Procedure

11Immunotherapy
01/2021 - 05/2005
6Therapeutics
02/2020 - 03/2010
5Drug Therapy (Chemotherapy)
11/2018 - 01/2013
3Induction Chemotherapy
01/2019 - 01/2016
1Aftercare (After-Treatment)
01/2021
1Blood Transfusion (Blood Transfusions)
02/2020
1Chelation Therapy (Therapy, Chelation)
02/2020
1Salvage Therapy
11/2018